{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:37:04Z","timestamp":1793054224066,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Councils","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12931-017-0570-5","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T14:56:19Z","timestamp":1494255379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Blood and sputum eosinophils in COPD; relationship with bacterial load"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3993-7848","authenticated-orcid":false,"given":"Umme","family":"Kolsum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin C.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan L.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga A.","family":"Wedzicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"570_CR1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1164\/rccm.201606-1179PP","volume":"194","author":"D Singh","year":"2016","unstructured":"Singh D, Roche N, Halpin D, Agusti A, Wedzicha JA, Martinez FJ. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2016;194:541\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","volume":"60","author":"CE Brightling","year":"2005","unstructured":"Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60:193\u20138.","journal-title":"Thorax"},{"key":"570_CR3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","volume":"356","author":"CE Brightling","year":"2000","unstructured":"Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356:1480\u20135.","journal-title":"Lancet"},{"key":"570_CR4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184:662\u201371.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR5","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1183\/13993003.01659-2015","volume":"47","author":"F Schleich","year":"2016","unstructured":"Schleich F, Corhay JL, Louis R. Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD. Eur Respir J. 2016;47:1562\u20134.","journal-title":"Eur Respir J"},{"key":"570_CR6","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","volume":"44","author":"D Singh","year":"2014","unstructured":"Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44:1697\u2013700.","journal-title":"Eur Respir J"},{"key":"570_CR7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S100338","volume":"11","author":"NA Negewo","year":"2016","unstructured":"Negewo NA, McDonald VM, Baines KJ, Wark PA, Simpson JL, Jones PW, Gibson PG. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1495\u2013504.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"570_CR8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","volume":"3","author":"S Pascoe","year":"2015","unstructured":"Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3:435\u201342.","journal-title":"Lancet Respir Med"},{"key":"570_CR9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","volume":"192","author":"SH Siddiqui","year":"2015","unstructured":"Siddiqui SH, Guasconi A, Vestbo J, Jones P, Agusti A, Paggiaro P, Wedzicha JA, Singh D. Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone\/Formoterol in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015;192:523\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","volume":"71","author":"ID Pavord","year":"2016","unstructured":"Pavord ID, Lettis S, Locantore N, Pascoe S, Jones PW, Wedzicha JA, Barnes NC. Blood eosinophils and inhaled corticosteroid\/long-acting beta-2 agonist efficacy in COPD. Thorax. 2016;71:118\u201325.","journal-title":"Thorax"},{"key":"570_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","volume":"186","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2012;186:48\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2147\/COPD.S80091","volume":"10","author":"M Bafadhel","year":"2015","unstructured":"Bafadhel M, Haldar K, Barker B, Patel H, Mistry V, Barer MR, Pavord ID, Brightling CE. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function. Int J Chron Obstruct Pulmon Dis. 2015;10:1075\u201383.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"570_CR13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/rccm.200509-1525OC","volume":"173","author":"S Sethi","year":"2006","unstructured":"Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:991\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1183\/09031936.99.14510159","volume":"14","author":"N Soler","year":"1999","unstructured":"Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015\u201322.","journal-title":"Eur Respir J"},{"key":"570_CR15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-015-1920-1","volume":"71","author":"D Singh","year":"2015","unstructured":"Singh D, Siew L, Christensen J, Plumb J, Clarke GW, Greenaway S, Perros-Huguet C, Clarke N, Kilty I, Tan L. Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects. Eur J Clin Pharmacol. 2015;71:1175\u201384.","journal-title":"Eur J Clin Pharmacol"},{"key":"570_CR16","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/thx.2006.071068","volume":"62","author":"J Bourbeau","year":"2007","unstructured":"Bourbeau J, Christodoulopoulos P, Maltais F, Yamauchi Y, Olivenstein R, Hamid Q. Effect of salmeterol\/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax. 2007;62:938\u201343.","journal-title":"Thorax"},{"key":"570_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15412550801941000","volume":"5","author":"M Boorsma","year":"2008","unstructured":"Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE. Long-term effects of budesonide on inflammatory status in COPD. COPD. 2008;5:97\u2013104.","journal-title":"COPD"},{"key":"570_CR18","doi-asserted-by":"crossref","first-page":"e42860","DOI":"10.1371\/journal.pone.0042860","volume":"7","author":"R Terradas","year":"2012","unstructured":"Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, Horcajada JP, Knobel H. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS One. 2012;7:e42860.","journal-title":"PLoS One"},{"key":"570_CR19","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/cc6883","volume":"12","author":"K Abidi","year":"2008","unstructured":"Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, Abouqal R. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care. 2008;12:R59.","journal-title":"Crit Care"},{"key":"570_CR20","doi-asserted-by":"crossref","unstructured":"ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111\u2013117.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"570_CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"570_CR22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1164\/ajrccm.154.4.8887576","volume":"154","author":"MM Pizzichini","year":"1996","unstructured":"Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996;154:866\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","volume":"106","author":"NR Anthonisen","year":"1987","unstructured":"Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196\u2013204.","journal-title":"Ann Intern Med"},{"key":"570_CR24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/thoraxjnl-2012-201924","volume":"67","author":"DS Garcha","year":"2012","unstructured":"Garcha DS, Thurston SJ, Patel AR, Mackay AJ, Goldring JJ, Donaldson GC, McHugh TD, Wedzicha JA. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67:1075\u201380.","journal-title":"Thorax"},{"key":"570_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1183\/09031936.00223113","volume":"44","author":"SN George","year":"2014","unstructured":"George SN, Garcha DS, Mackay AJ, Patel AR, Singh R, Sapsford RJ, Donaldson GC, Wedzicha JA. Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J. 2014;44:87\u201396.","journal-title":"Eur Respir J"},{"key":"570_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1378\/chest.14-0764","volume":"147","author":"BL Barker","year":"2015","unstructured":"Barker BL, Haldar K, Patel H, Pavord ID, Barer MR, Brightling CE, Bafadhel M. Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations. Chest. 2015;147:46\u201355.","journal-title":"Chest"},{"key":"570_CR27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12931-014-0114-1","volume":"15","author":"R Singh","year":"2014","unstructured":"Singh R, Mackay AJ, Patel AR, Garcha DS, Kowlessar BS, Brill SE, Donnelly LE, Barnes PJ, Donaldson GC, Wedzicha JA. Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease. Respir Res. 2014;15:114.","journal-title":"Respir Res"},{"key":"570_CR28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000330667","volume":"83","author":"M Bafadhel","year":"2012","unstructured":"Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, et al. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 2012;83:36\u201344.","journal-title":"Respiration"},{"key":"570_CR29","first-page":"179","volume":"9","author":"R Siva","year":"2014","unstructured":"Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID. Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis. 2014;9:179\u201386.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"570_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12931-016-0462-0","volume":"17","author":"M Wang","year":"2016","unstructured":"Wang M, Gao P, Wu X, Chen Y, Feng Y, Yang Q, Xu Y, Zhao J, Xie J. Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma. Respir Res. 2016;17:153.","journal-title":"Respir Res"},{"key":"570_CR31","doi-asserted-by":"crossref","unstructured":"Bafadhel M, Greening NJ, Harvey-Dunstan TC, Williams JE, Morgan MD, Brightling CE, Hussain SF, Pavord ID, Singh SJ, Steiner MC. Blood eosinophils and outcomes in severe hospitalised exacerbations of COPD. Chest. 2016;150(2):320\u20138.","DOI":"10.1016\/j.chest.2016.01.026"},{"key":"570_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pupt.2016.03.004","volume":"37","author":"L Serafino-Agrusa","year":"2016","unstructured":"Serafino-Agrusa L, Scichilone N, Spatafora M, Battaglia S. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case\u2013control study. Pulm Pharmacol Ther. 2016;37:89\u201394.","journal-title":"Pulm Pharmacol Ther"},{"key":"570_CR33","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101:1644\u201355.","journal-title":"Chest"},{"key":"570_CR34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-1843.2009.01651.x","volume":"15","author":"M Holland","year":"2010","unstructured":"Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. 2010;15:165\u20137.","journal-title":"Respirology"},{"key":"570_CR35","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/thoraxjnl-2012-202103","volume":"67","author":"J Steer","year":"2012","unstructured":"Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67:970\u20136.","journal-title":"Thorax"},{"key":"570_CR36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/adc.73.4.333","volume":"73","author":"D Spallarossa","year":"1995","unstructured":"Spallarossa D, Sacco O, Girosi D, Rossi GA. Blood eosinophil counts and arterial oxygen tension in acute asthma. Arch Dis Child. 1995;73:333\u20137.","journal-title":"Arch Dis Child"},{"key":"570_CR37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/rccm.201205-0806OC","volume":"186","author":"P Mallia","year":"2012","unstructured":"Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo MB, Kebadze T, Aniscenko J, Oleszkiewicz G, Gray K, et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:1117\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"570_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2012.03556.x","volume":"136","author":"AM Kvarnhammar","year":"2012","unstructured":"Kvarnhammar AM, Cardell LO. Pattern-recognition receptors in human eosinophils. Immunology. 2012;136:11\u201320.","journal-title":"Immunology"},{"key":"570_CR39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm.1855","volume":"14","author":"S Yousefi","year":"2008","unstructured":"Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E, Schmid I, Straumann A, Reichenbach J, Gleich GJ, Simon HU. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008;14:949\u201353.","journal-title":"Nat Med"},{"key":"570_CR40","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.4049\/jimmunol.142.12.4428","volume":"142","author":"RI Lehrer","year":"1989","unstructured":"Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol. 1989;142:4428\u201334.","journal-title":"J Immunol"},{"key":"570_CR41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI108166","volume":"56","author":"DA Bass","year":"1975","unstructured":"Bass DA. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest. 1975;56:870\u20139.","journal-title":"J Clin Invest"},{"key":"570_CR42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.V3.7.755.755","volume":"3","author":"AG Hills","year":"1948","unstructured":"Hills AG, Forsham PH, Finch CA. Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotrophic hormone in man. Blood. 1948;3:755\u201368.","journal-title":"Blood"},{"key":"570_CR43","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.rmed.2014.09.020","volume":"108","author":"S Khurana","year":"2014","unstructured":"Khurana S, Ravi A, Sutula J, Milone R, Williamson R, Plumb J, Vestbo J, Singh D. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med. 2014;108:1761\u201370.","journal-title":"Respir Med"},{"key":"570_CR44","doi-asserted-by":"crossref","first-page":"e000151","DOI":"10.1136\/bmjresp-2016-000151","volume":"3","author":"JL Kreindler","year":"2016","unstructured":"Kreindler JL, Watkins ML, Lettis S, Tal-Singer R, Locantore N. Effect of inhaled corticosteroids on blood eosinophil count in steroid-naive patients with COPD. BMJ Open Respir Res. 2016;3:e000151.","journal-title":"BMJ Open Respir Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-017-0570-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T13:14:14Z","timestamp":1692796454000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-017-0570-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1186\/s12931-017-0570-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"article-number":"88"}}